Guaifenesin
NDC 81993-002, Guaifenesin 400 mg, tablet, from Zennova LLC.
- Product NDC
- 81993-002
- Status
- Listed
- Labeler
- Zennova LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81993-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN400 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81993-002-01 | 81993000201 | 1 BOTTLE in 1 CARTON (81993-002-01) / 14 TABLET in 1 BOTTLE |
| 81993-002-02 | 81993000202 | 60 TABLET in 1 BOTTLE (81993-002-02) |
| 81993-002-03 | 81993000203 | 1 BOTTLE in 1 CARTON (81993-002-03) / 100 TABLET in 1 BOTTLE |
| 81993-002-04 | 81993000204 | 200 TABLET in 1 BOTTLE (81993-002-04) |
| 81993-002-05 | 81993000205 | 1 BOTTLE in 1 CARTON (81993-002-05) / 300 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 81993-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81993-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81993-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.